← Back to Search

Motor Memory Assessment for Post-COVID Syndrome

N/A
Recruiting
Led By Leonardo G Cohen, M.D.
Research Sponsored by National Institute of Neurological Disorders and Stroke (NINDS)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Deny active infection with COVID-19, or ongoing symptoms following COVID-19 infection
Enrolled in the screening phase of Protocol 000089 Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health in the post-COVID convalescence arm (i.e. reports having started recovery from an acute COVID- 19 infection within past six month and is able to provide documentation of a positive COVID-19 PCR or antibody test)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up anticipated to complete data analysis by december 2023
Awards & highlights

Study Summary

This trial looks at motor memory in people with long COVID vs. healthy adults, by having them complete typing and questionnaire tasks online.

Who is the study for?
This trial is for adults aged 18-90 who have recovered from COVID-19 but may experience long-term effects, known as long COVID. Participants must be able to type with their nondominant hand and have internet access. They cannot join if they've had recent fever or respiratory symptoms, unresolved neurologic symptoms post-COVID, or pre-existing conditions like large strokes or severe psychiatric disorders.Check my eligibility
What is being tested?
The study aims to test motor memory in people with long COVID by having them perform typing tasks using their nondominant hand over two days. The tasks are completed online and involve repeatedly typing a number sequence within specific time intervals followed by questionnaires about their experiences.See study design
What are the potential side effects?
Since the intervention involves only keypresses on a keyboard, there are no direct medical side effects associated with this trial. However, participants should not experience discomfort while typing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have COVID-19 and am not experiencing lingering symptoms.
Select...
I am recovering from COVID-19 and enrolled in a specific NIH post-COVID study.
Select...
I am between 18 and 90 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~anticipated to complete data analysis by december 2023
This trial's timeline: 3 weeks for screening, Varies for treatment, and anticipated to complete data analysis by december 2023 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To investigate differences in procedural memory formation and consolidation during a keyboard typing task between o patients withpersistent symptoms following COVID- 19 infection ( long COVID )and matched controls who deny symptoms of ...

Trial Design

4Treatment groups
Experimental Treatment
Group I: Arm 2 Healthy Controls right handedExperimental Treatment1 Intervention
healthy right handed
Group II: Arm 2 Healthy Controls left handedExperimental Treatment1 Intervention
healthy left handed
Group III: Arm 1 Long COVID right handedExperimental Treatment1 Intervention
Long COVID right handed
Group IV: Arm 1 Long COVID left handedExperimental Treatment1 Intervention
Long COVID left handed

Find a Location

Who is running the clinical trial?

National Institute of Neurological Disorders and Stroke (NINDS)Lead Sponsor
1,340 Previous Clinical Trials
648,364 Total Patients Enrolled
41 Trials studying Ischemic Stroke
25,353 Patients Enrolled for Ischemic Stroke
Leonardo G Cohen, M.D.Principal InvestigatorNational Institute of Neurological Disorders and Stroke (NINDS)
12 Previous Clinical Trials
5,804 Total Patients Enrolled

Media Library

Arm 1 Long COVID right handed Clinical Trial Eligibility Overview. Trial Name: NCT05746624 — N/A
Ischemic Stroke Research Study Groups: Arm 1 Long COVID right handed, Arm 1 Long COVID left handed, Arm 2 Healthy Controls left handed, Arm 2 Healthy Controls right handed
Ischemic Stroke Clinical Trial 2023: Arm 1 Long COVID right handed Highlights & Side Effects. Trial Name: NCT05746624 — N/A
Arm 1 Long COVID right handed 2023 Treatment Timeline for Medical Study. Trial Name: NCT05746624 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the upper age limit for this trial set at 85 years?

"This clinical trial requires that participants are over the age of consent but no older than 90."

Answered by AI

Who can qualify to take part in the clinical trial?

"To be eligible for participation, patients must have been affected by stroke and aged between 18 to 90 years old. A maximum of 1000 individuals will be included in this clinical trial."

Answered by AI

Is this trial accepting participants at the moment?

"Data from clinicaltrials.gov reveals that this medical trial is currently welcoming participants; it was first announced on March 5th, 2023 and went through a most recent update on February 27th, 2023."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Procedural Motor Memory in Long COVID-19
2021. "Procedural Motor Memory in Long COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05746624.
All > Survivor Corps
~216 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top